Literature DB >> 18716715

Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of thiazolone derivatives as hepatitis C virus NS5B polymerase allosteric inhibitors.

Beilei Lei1, Juan Du, Shuyan Li, Huanxiang Liu, Yueying Ren, Xiaojun Yao.   

Abstract

Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a series of thiazolone derivatives as novel inhibitors bound to the allosteric site of hepatitis C virus (HCV) NS5B polymerase were developed based on CoMFA and CoMSIA analyses. Two different conformations of the template molecule and the combinations of different CoMSIA field/fields were considered to build predictive CoMFA and CoMSIA models. The CoMFA and CoMSIA models with best predictive ability were obtained by the use of the template conformation from X-ray crystal structures. The best CoMFA and CoMSIA models gave q (2) values of 0.621 and 0.685, and r (2) values of 0.950 and 0.940, respectively for the 51 compounds in the training set. The predictive ability of the two models was also validated by using a test set of 16 compounds which gave r (pred) (2) values of 0.685 and 0.822, respectively. The information obtained from the CoMFA and CoMSIA 3D contour maps enables the interpretation of their structure-activity relationship and was also used to the design of several new inhibitors with improved activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716715     DOI: 10.1007/s10822-008-9230-7

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  35 in total

1.  3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach.

Authors:  Zhuoyong Zhang; Liying An; Wenxiang Hu; Yuhong Xiang
Journal:  J Comput Aided Mol Des       Date:  2007-01-04       Impact factor: 3.686

2.  Compass: predicting biological activities from molecular surface properties. Performance comparisons on a steroid benchmark.

Authors:  A N Jain; K Koile; D Chapman
Journal:  J Med Chem       Date:  1994-07-22       Impact factor: 7.446

3.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

4.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

5.  Inhibitors of HCV NS5B polymerase. Part 2: Evaluation of the northern region of (2Z)-2-benzoylamino-3-(4-phenoxy-phenyl)-acrylic acid.

Authors:  Jeffrey A Pfefferkorn; Richard Nugent; Rebecca J Gross; Meredith Greene; Mark A Mitchell; Matthew T Reding; Lee A Funk; Rebecca Anderson; Peter A Wells; John A Shelly; Robert Anstadt; Barry C Finzel; Melissa S Harris; Robert E Kilkuskie; Laurice A Kopta; Francis J Schwende
Journal:  Bioorg Med Chem Lett       Date:  2005-06-02       Impact factor: 2.823

6.  Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid.

Authors:  Jeffrey A Pfefferkorn; Meredith L Greene; Richard A Nugent; Rebecca J Gross; Mark A Mitchell; Barry C Finzel; Melissa S Harris; Peter A Wells; John A Shelly; Robert A Anstadt; Robert E Kilkuskie; Laurice A Kopta; Francis J Schwende
Journal:  Bioorg Med Chem Lett       Date:  2005-05-16       Impact factor: 2.823

7.  Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.

Authors:  Ariamala Gopalsamy; Kitae Lim; Gregory Ciszewski; Kaapjoo Park; John W Ellingboe; Jonathan Bloom; Shabana Insaf; Janis Upeslacis; Tarek S Mansour; Girija Krishnamurthy; Murthy Damarla; Yelena Pyatski; Douglas Ho; Anita Y M Howe; Mark Orlowski; Boris Feld; John O'Connell
Journal:  J Med Chem       Date:  2004-12-16       Impact factor: 7.446

8.  Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109.

Authors:  Shintaro Hirashima; Takayoshi Suzuki; Tomio Ishida; Satoru Noji; Shinji Yata; Izuru Ando; Masakazu Komatsu; Satoru Ikeda; Hiromasa Hashimoto
Journal:  J Med Chem       Date:  2006-07-27       Impact factor: 7.446

9.  Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site.

Authors:  Ariamala Gopalsamy; Rajiv Chopra; Kitae Lim; Gregory Ciszewski; Mengxiao Shi; Kevin J Curran; Steven F Sukits; Kristine Svenson; Joel Bard; John W Ellingboe; Atul Agarwal; Girija Krishnamurthy; Anita Y M Howe; Mark Orlowski; Boris Feld; John O'Connell; Tarek S Mansour
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

10.  Discovery of alpha,gamma-diketo acids as potent selective and reversible inhibitors of hepatitis C virus NS5b RNA-dependent RNA polymerase.

Authors:  Vincenzo Summa; Alessia Petrocchi; Paola Pace; Victor G Matassa; Raffaele De Francesco; Sergio Altamura; Licia Tomei; Uwe Koch; Philippe Neuner
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

View more
  1 in total

1.  QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine.

Authors:  Eslam Pourbasheer; Siavash Riahi; Mohammad Reza Ganjali; Parviz Norouzi
Journal:  Mol Divers       Date:  2010-10-08       Impact factor: 2.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.